“Indar” to Hold Shareholders' Meeting on June 16

24.05.2026    12:16

PJSC “Indar” Insulin Manufacturing has scheduled a general meeting of shareholders for June 16, 2026, according to a notice posted on the SMIDA disclosure system. The meeting will be held remotely.

Indar PJSC was registered on October 31, 1997, with EDRPOU code 21680915. According to OpenDataBot, the company’s authorized capital is UAH 80.886 million, and Lyubov Vyshnevska is listed as the CEO. The registered address is Kyiv, 5 Zroshuvana St. The primary business activity is the production of pharmaceuticals and materials.

According to the company’s own information, Indar is a full-cycle manufacturer of genetically engineered insulins—from active ingredients to finished dosage forms—and has over 20 years of experience in the research and production of pharmaceuticals.

The company previously reported that 70.7% of Indar’s shares are owned by the state, while Lurak Investments Limited became the owner of 29.3% of the shares.

Indar is one of Ukraine’s key insulin manufacturers. During the war, the importance of such enterprises has increased due to the need to maintain domestic production of critically important medicines and reduce dependence on imports.

Теги:   Indar Переглядів:   50